Literature DB >> 2285652

5-Hydroxytryptamine induces contraction in isolated human mammary artery: effect of ketanserin.

A Monopoli1, A Conti, A Forlani, E Ongini, C Antona, P Biglioli.   

Abstract

5-hydroxytryptamine (5HT) treatment produced dose-related contractions in the human internal mammary artery with an EC50 value of 3.4 X 10(-7) M. The 5HT2 receptor antagonist ketanserin reversed the contractions evoked by 5HT in a competitive manner at a low concentration (10(-8) M), whereas a noncompetitive antagonism was apparent at higher concentrations (5 X 10(-8) M to 5 X 10(-7) M). The alpha 1-blocking component of ketanserin was evaluated by studying the effect of ketanserin upon the contractile response evoked by norepinephrine. Up to 10(-7) M, ketanserin did not influence norepinephrine-induced contractions. These findings indicate that the mammary artery is a vascular tissue sensitive to contractions induced by 5HT and that the drug ketanserin antagonizes this contractile response through the 5HT2 receptor subtype.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2285652     DOI: 10.1007/bf00053428

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  10 in total

Review 1.  Cardiovascular effects of serotonin.

Authors:  P M Vanhoutte
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

2.  Ketanserin--a new antihypertensive agent.

Authors:  A Breckenridge
Journal:  J Hypertens Suppl       Date:  1986-04

3.  Pharmacology of arterioles: some aspects of variability in response to norepinephrine, histamine, and 5-hydroxytryptamine.

Authors:  M E Burrows; P M Vanhoutte
Journal:  J Cardiovasc Pharmacol       Date:  1981 Nov-Dec       Impact factor: 3.105

4.  Interaction of selected vasodilating beta-blockers with adrenergic receptors in human cardiovascular tissues.

Authors:  A Monopoli; A Forlani; M Bevilacqua; T Vago; G Norbiato; P Bertora; P Biglioli; F Alamanni; E Ongini
Journal:  J Cardiovasc Pharmacol       Date:  1989-07       Impact factor: 3.105

5.  5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery.

Authors:  A A Parsons; E T Whalley; W Feniuk; H E Connor; P P Humphrey
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

6.  Serotonin induced vasodilatation in the human forearm is antagonized by the selective 5-HT3 receptor antagonist ICS 205-930.

Authors:  G J Blauw; P van Brummelen; P A van Zwieten
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

7.  Cardiovascular effects of ketanserin in the treatment of hypertension during coronary artery bypass surgery.

Authors:  J A Richter; A Barankay; E Göb; P Späth
Journal:  J Cardiovasc Pharmacol       Date:  1986 Jan-Feb       Impact factor: 3.105

Review 8.  Serotonin and the vascular system. Role in health and disease, and implications for therapy.

Authors:  D S Houston; P M Vanhoutte
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

Review 9.  Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin.

Authors:  P Vanhoutte; A Amery; W Birkenhäger; A Breckenridge; F Bühler; A Distler; J Dormandy; A Doyle; E Frohlich; L Hansson
Journal:  Hypertension       Date:  1988-02       Impact factor: 10.190

10.  The alpha-adrenergic receptor blocking effect of ketanserin and the interaction between alpha-adrenergic and S2-serotonergic receptor blockade.

Authors:  P J van der Starre; R S Reneman
Journal:  J Cardiovasc Pharmacol       Date:  1988       Impact factor: 3.105

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.